Smith & Nephew plc (NYSE:SNN) Receives Consensus Rating of “Hold” from Analysts

Shares of Smith & Nephew plc (NYSE:SNN) have been assigned an average rating of “Hold” from the five research firms that are presently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company.

Separately, StockNews.com raised shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Friday, March 15th.

Smith & Nephew Stock Up 2.4 %

SNN stock opened at $24.45 on Tuesday. Smith & Nephew has a one year low of $21.52 and a one year high of $33.08. The company’s 50 day moving average price is $25.99 and its two-hundred day moving average price is $25.98. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.77 and a quick ratio of 0.72.

Smith & Nephew Announces Dividend

The business also recently declared a semi-annual dividend, which will be paid on Wednesday, May 22nd. Investors of record on Tuesday, April 2nd will be issued a $0.462 dividend. This represents a yield of 2.8%. The ex-dividend date of this dividend is Monday, April 1st.

Institutional Trading of Smith & Nephew

Several large investors have recently added to or reduced their stakes in SNN. CWM LLC boosted its holdings in Smith & Nephew by 68.6% in the fourth quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 388 shares in the last quarter. Allworth Financial LP boosted its holdings in Smith & Nephew by 1,566.2% in the third quarter. Allworth Financial LP now owns 1,133 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 1,065 shares in the last quarter. Spire Wealth Management boosted its holdings in Smith & Nephew by 224.3% in the fourth quarter. Spire Wealth Management now owns 1,015 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 702 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in Smith & Nephew by 75.0% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,227 shares of the medical equipment provider’s stock valued at $33,000 after acquiring an additional 526 shares in the last quarter. Finally, Parallel Advisors LLC boosted its holdings in Smith & Nephew by 150.9% in the fourth quarter. Parallel Advisors LLC now owns 1,533 shares of the medical equipment provider’s stock valued at $42,000 after acquiring an additional 922 shares in the last quarter. Institutional investors own 25.64% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.